Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.922,47
-0,12%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Morphic Holding Inc (MORF) Morphic Holding Inc (MORF) Notizie

Morphic Holding Inc

MORF
29,90
1,19 (4,14%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/4/202413:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
19/3/202413:00GLOBEMorphic Appoints Dr. Simon Cooper as Chief Medical Officer
05/3/202422:05GLOBEMorphic to Participate in March Investor Conferences
22/2/202413:46EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202413:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202413:04EDGAR2Form 8-K - Current report
22/2/202413:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
18/1/202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:08EDGAR2Form 8-K - Current report
03/1/202422:05GLOBEMorphic to Present at the 42nd Annual J.P. Morgan Healthcare..
06/12/202314:57EDGAR2Form 8-K - Current report
10/11/202314:00GLOBEMorphic to Present at November Investor Conferences
03/11/202312:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202312:13EDGAR2Form 8-K - Current report
03/11/202312:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
12/10/202314:52EDGAR2Form 8-K - Current report
09/10/202314:00GLOBEMorphic Therapeutic to Host Webcast to Present EMERALD-1..
26/9/202323:30EDGAR2Form 8-K - Current report
26/9/202322:10GLOBEMorphic Holdings Announces CEO Dr. Praveen Tipirneni to Take..
22/9/202323:30GLOBEMorphic to Present Positive EMERALD-1 Phase 2a Data for..
09/9/202301:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202322:24EDGAR2Form 144 - Report of proposed sale of securities
29/8/202314:00GLOBEMorphic Announces Participation in 2023 Wells Fargo..
09/8/202322:05GLOBEMorphic to Present at the Canaccord Genuity 43rd Annual..
04/8/202300:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202313:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202313:08EDGAR2Form 8-K - Current report
03/8/202313:05GLOBEMorphic Announces Corporate Highlights and Financial Results..
07/7/202301:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202322:05GLOBEMorphic to Present at the Jefferies Global Healthcare..
12/5/202314:30GLOBEMorphic to Present at 2023 RBC Capital Markets Global..
11/5/202314:00GLOBEMorphic Presents New Biomarker Data at DDW 2023 Supporting..
Apertura: 29,85 Min: 29,075 Max: 30,30
Chiusura: 28,71

La tua Cronologia

NASDAQ
MORF
Morphic
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network